High gene expression of TS1, GSTP1, and ERCC1 are risk factors for survival in patients treated with trimodality therapy for esophageal cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/15788669

Clin. Cancer Res. 2005 Mar 15 11 6 2215-21

Download in:

View as

General Info

PMID
15788669